Company

Teva Pharmaceutical Industries Limited

Headquarters: Petah Tikva, Israel

Employees: 34,713

CEO: Mr. Kare Schultz

TASE: TEVA -0.66%

Market Cap

₪71.08 Billion

ILS as of July 1, 2024

US$18.88 Billion

Market Cap History

Teva Pharmaceutical Industries Limited market capitalization over time

Evolution of Teva Pharmaceutical Industries Limited market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Teva Pharmaceutical Industries Limited

Detailed Description

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.

Top 1-year algo backtest: +207.50%

$10,000 in July 2023 would now be $30,750 by following this algorithm daily at market close.

Boost your investing & swing trading... Now!

Try Disfold DeepFinance FREE

Stocks & Indices

Teva Pharmaceutical Industries Limited has the following listings and related stock indices.


Stock: TASE: TEVA wb_incandescent

Stock: NYSE: TEVA wb_incandescent

Stock: OTC: TEVJF wb_incandescent

Stock: FSX: TEV wb_incandescent

Details

Headquarters:

5 Basel Street

Petah Tikva, 4951033

Israel

Phone: 972 3 914 8171